Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Xphyto
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
Xphyto Therapeutics’ (XPHY.C) potential deal with German brewery Oettinger Brauerei GmbH means development, production and distribution of cannabis-infused beverages for the European Market. They take their beer seriously in…
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple…
Xphyto Therapeutics (XPHY.C) announced today that they advancing its thin film CBD delivery system for epilepsy sufferers to clinical trials. In the past three months, the company’s German subsidiary,…
Xphyto Therapeutics (XPHY.C) German subsidiary Vektor Pharma TF GmbH will commence several research and development programs related to infectious disease, including thin film delivery of cannabigerol (CBG) and quercetic…
Xphyto (XPHY.C) is dominating the cannabis sector like Sean Kemp used to dominate the Seattle buffet scene. It’s a legit beast right now, jumping from fat new high to…